AKT Inhibitor in Oestrogen Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer
Interventions: DRUG: AZD5363
Sponsor: University of Nottingham
Collaborators: AstraZeneca|Cancer Research UK|National Cancer Research Network